Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Kiniksa Pharmaceuticals International PLC fell by 14.76m. However, the company earned 13.30m from its operations for a Cash Flow Margin of 4.92%. In addition the company generated 1.50m cash from financing while 29.56m was spent on investing.
Cash flow per share | -0.0994 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.06 |
---|---|
Tangible book value per share | 5.83 |
More ▼
Balance sheet in USDView more
Current ratio | 3.24 |
---|---|
Quick ratio | 2.95 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼